Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Mpm Bioimpact Llc
Form 13F · Q2 2026

Mpm Bioimpact Llc

CIK 1687078申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$16.4亿
申報組合市值
37
持倉數量
12
Quarters on record
Top 50
持倉數量

Mpm Bioimpact Llc——持倉

共 37 個持倉中的前 37 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1CGEM Cullinan Therapeutics Inc9.7M+27.2%$1.8亿10.8%
2AKTS Aktis Oncology Inc4.8M+0.0%$1.6亿9.5%
3LQDA Liquidia Corporation1.4M−1.4%$1.1亿6.7%
4RVMD Revolution Medicines Inc492,483−2.8%$9223万5.6%
5CORT Corcept Therapeutics Inc771,028−21.8%$6704万4.1%
6EWTX Edgewise Therapeutics Inc1.6M−2.4%$6585万4.0%
7TVTX Travere Therapeutics Inc1.1M−0.9%$6378万3.9%
8DBVT Dbv Technologies S A3.7M−29.7%$6013万3.7%
9TRVI Trevi Therapeutics Inc3.1M−6.8%$5732万3.5%
10ALMS Alumis Inc2.0M−15.4%$5682万3.5%
11QURE Uniqure Nv1.2M−10.5%$5646万3.4%
12RARE Ultragenyx Pharmaceutical In1.4M—$4735万2.9%
13RLAY Relay Therapeutics Inc2.4M+2.4%$4520万2.8%
14ABVX Abivax Sa336,347+213.6%$4482万2.7%
15DYN Dyne Therapeutics Inc1.9M+36.5%$4269万2.6%
16DNTH Dianthus Therapeutics Inc420,002−0.9%$4094万2.5%
17BIOA Bioage Labs Inc1.7M—$4087万2.5%
18URGN Urogen Pharma Ltd933,415−1.1%$3435万2.1%
19MLTX Moonlake Immunotherapeutics1.6M−11.3%$3129万1.9%
20PVLA Palvella Therapeutics Inc Ne204,027−1.2%$3118万1.9%
21TSHA Taysha Gene Therapies Inc4.5M—$3064万1.9%
22SNDX Syndax Pharmaceuticals Inc1.3M−0.5%$2915万1.8%
23GLUE Monte Rosa Therapeutics Inc1.2M−1.3%$2810万1.7%
24ZURA Zura Bio Ltd4.5M—$2639万1.6%
25NTRA Natera Inc92,638−0.5%$2515万1.5%
26STOK Stoke Therapeutics Inc723,314−5.7%$2367万1.4%
27ANL Adlai Nortye Ltd1.9M—$2227万1.4%
28BLTE Belite Bio Inc137,208+55.8%$2113万1.3%
29FORTE BIOSCIENCES INC Forte Biosciences Inc987,448−1.3%$2098万1.3%
30ORIC Oric Pharmaceuticals Inc1.9M+4.3%$2038万1.2%
31TARS Tarsus Pharmaceuticals Inc322,007−2.3%$2027万1.2%
32ANNX Annexon Inc3.5M—$2024万1.2%
33DRUG Bright Minds Biosciences Inc202,114−4.7%$1419万0.9%
34TRDA Entrada Therapeutics Inc1.3M—$922万0.6%
35ACRS Aclaris Therapeutics Inc1.0M+166.0%$551万0.3%
36CNTX Context Therapeutics Inc1.3M−87.8%$72万0.0%
37HOWL Werewolf Therapeutics Inc80,142−93.4%$3万0.0%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。